RALGAPA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.24319998739963E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.045700E-04 |
Normal-vs-Stage2 |
7.220300E-04 |
Normal-vs-Stage3 |
3.18745030369882E-13 |
Normal-vs-Stage4 |
1.66466840312296E-12 |
Stage1-vs-Stage2 |
4.297000E-01 |
Stage1-vs-Stage3 |
1.218700E-04 |
Stage1-vs-Stage4 |
1.67750999999772E-05 |
Stage2-vs-Stage3 |
5.930300E-02 |
Stage2-vs-Stage4 |
1.542000E-02 |
Stage3-vs-Stage4 |
3.552600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.07259986950703E-10 |
Normal-vs-AfricanAmerican |
1.50745999999424E-05 |
Normal-vs-Asian |
4.610100E-02 |
Caucasian-vs-AfricanAmerican |
6.167800E-01 |
Caucasian-vs-Asian |
7.453200E-01 |
AfricanAmerican-vs-Asian |
7.785600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.58849641510528E-11 |
Normal-vs-Female |
1.61720000002585E-06 |
Male-vs-Female |
7.262500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.27350000003845E-06 |
Normal-vs-Age(41-60Yrs) |
8.16500000000442E-05 |
Normal-vs-Age(61-80Yrs) |
5.36570787801338E-13 |
Normal-vs-Age(81-100Yrs) |
1.04840000003659E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.415650E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.108800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.400600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.958000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.119500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.167600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.210800E-01 |
Normal-vs-Grade 2 |
1.002310E-04 |
Normal-vs-Grade 3 |
2.14649997776206E-09 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
5.791700E-02 |
Grade 1-vs-Grade 3 |
4.030100E-04 |
Grade 1-vs-Grade 4 |
3.22219999571161E-08 |
Grade 2-vs-Grade 3 |
4.360100E-03 |
Grade 2-vs-Grade 4 |
1.73549952187102E-10 |
Grade 3-vs-Grade 4 |
2.441500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.626500E-02 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
6.78020000144386E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.01509944683676E-11 |
Normal-vs-N1 |
3.26060289879138E-11 |
N0-vs-N1 |
3.443000E-04 |
|
|